MyAverix Finance MyAverix Finance

BE · Other

CATALYST PHARMA PTR (CN2)

Other

CATALYST PHARMA PTR (CN2) is listed on BE in the Other sector. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-22

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for CN2

P/E ratio
18.00

CATALYST PHARMA PTR (CN2) — FAQ

What is CN2's P/E ratio?

The price-to-earnings (P/E) ratio for CATALYST PHARMA PTR (CN2) is 18.00 (data as of 2026-03-22).

Does CATALYST PHARMA PTR pay a dividend?

Dividend yield is not available in the current snapshot for CATALYST PHARMA PTR (CN2). Check the MyAverix Finance app for the latest dividend data.

What sector is CATALYST PHARMA PTR in?

CATALYST PHARMA PTR (CN2) is classified in the Other sector.

What exchange is CN2 listed on?

CN2 is listed on BE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Other companies

Apple Inc (APC) Microsoft Corporation (MSF)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play